SORT BY Relevancy
Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig is Jeff Lee, CEO, Omniscience to discuss featured news and trends in clinical trial innovation and in particular mobile applications.
Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer, Inc.
Jeffrey Kasher, PhD, VP & COO, Eli Lilly & Company
Jeff Lee, CEO, Omniscience Mobile
Rick Sax, MD, SVP Clinical Design & Reporting Services, Quintiles
A panel of executives from leading pharma and the venture capital community at the DPharm Disruptive Innovations conference recently awarded the 2013 Disruptive Innovator of the Year title to Medidata Solutions and Spaulding Clinical Research. They won for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community.
Host Craig Lipset, Head of Clinical Innovation, R&D at Pfizer speaks with Dr. Andrew Lee of Sanofi on key takeaways from the 2013 DPharm conference along with the CEOs of the winning companies to learn more about their collaboration.
Andrew Lee, MD, SVP, Deputy Head of Clinical Sciences & Operations, Sanofi
Glen De Vries, President of Medidata Solutions
Randy Spaulding, Founder and CEO of Spaulding Clinical Research
Join us in a discussion on serving patients in clinical trials.
Making clinical trials more accessible for patients Emerging technologies / iPads and informed consent Disruption Headlines in the news Host:
Craig Lipset, MBA Head of Clinical Innovation, R&D, Pfizer Inc.
Andreas Koester, MD, PhD VP, Clinical Trial Innovation & External Alliances, Janssen
Anthony Costello, CEO, Mytrus
Join host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer with guests Joe Kim, Clinical Operations Director, Shire and Dr. Hugo Stevenson, physician and serial entrepreneur, as they discuss innovation transforming the clinical trial space to include: * Mobile technology and apps * Clinical trials and diversity * Google Glass for health * Investigator database sharing * Key motivations for innovators and moreThe opinions shared by Craig and our guests are those of the speakers and do not necessarily reflect the opinions of their employers.
Drs. Christopher Gallen, CEO at SK BioPharmaceuticals and Mitchell Katz, Executive Director, Medical Research Operations at Purdue Pharma, in a candid conversation on navigating the complexities of Global Clinical Trials and addressing topics including: Why global trials? Why are global trials so expensive? How are companies re-thinking global trials? What's happening with global outsourcing? Thoughts on emerging markets and patient recruitment What can we do to help mitigate the risks of global trials?
TOPIC: Depression in the Workplace
Despite being one of the most common causes of disability around the world, depression is largely misunderstood and often hidden or ignored. If you’d like to know more about this illness, and how to reduce the damage it causes, then tune in on Monday September 23 at 10 AM. Dennis will be speaking with Stephanie Peter, a Registered Clinical Counsellor with 15 years of experience helping people return to work safely after injury or illness. We'll discuss the warning signs of depression, why people wait to get help, treatments that are effective, and practical strategies that can be implemented in the workplace. Call in with your questions, or join the chatroom!
Phone: 250-616-0502 Nanaimo; 250-937-1223 Parksville
Dr. Ajai-Chari from Mout Sinai Hospital, New York, is the featured guest on our Myeloma talk series in September scheduled for 26 September @ 6pm ET.
Dr. Chari is a renowned myeloma expert. Dr. Chari would be discussing Clinical Trials on Myeloma on the show with patient experts, Gary Petersen, Jack Aiello, Pat Killingsworth, Cynthia Chmielewski and Lizzy Smith.
“Susan is an APTA Board Certified Neurological Clinical Specialist and works as a Clinical Assistant Faculty member at the University of Montana’s School of Physical Therapy, where she teaches in the areas of neurological rehabilitation, clinical decision making, and interventions. She is the director of the University of Montana Physical Therapy Clinic and assists with management of the New Directions Wellness Center, providing physical therapy services and an accessible, assisted fitness center. Susan has worked as a physical therapist for 20 years and continues to treat patients with neurological and other chronic conditions. “
Helen Blair Simpson, MD, PhD, Director of the Anxiety Disorders Clinic and the Center for OCD and Related Disorders at the New York State Psychiatric Institute/Columbia University Medical Center
Moira Rynn, MD, Director of the Division of Child & Adolescent Psychiatry and Pediatric Anxiety and Mood Research Clinic at the New York State Psychiatric Institute/Columbia University Medical Center
Dr. Helen Blair Simpson and Dr. Moira Rynn will talk about what we have learned so far in clinical research and what we are doing now for the patients of today and tomorrow. They will address what we have learned about biological research and the brain mechanisms related to OCD symptoms. Finally, they will discuss updates on clinical trials that they are currently conducting for adult, adolescent and child OCD patients.
For more information on OCD treatment and research opportunities for adults, please visit our clinic website at www.Columbia-OCD.org and our treatment study website at http://ocdtreatmentstudy.com/ or call us at 212-543-5462.
For more information on OCD treatment and research opportunities for children and adolescents, please visit our website http://columbiapsychiatry.org/pamrc or call us at 212-543-5592.
Clinical psychologist and author of Ponerology: The Science of Evil Adjusted for Political Purposes, Andrew Lobaczewski, coined the phrase "Pathocracy" that I used in the title of my book, American Heart of Darkness: The Transformation of the American Republic into a Pathocracy. What this term means to the American People and the rest of the world today, and what to do about it, is the subject of this half hour talk show.